Welcome to LookChem.com Sign In|Join Free
  • or
1H-1,4-Diazepine,hexahydro-1-methyl-4-(1-oxo-2-propenyl)-(9CI) is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

775288-08-9

Post Buying Request

775288-08-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

775288-08-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 775288-08-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,7,5,2,8 and 8 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 775288-08:
(8*7)+(7*7)+(6*5)+(5*2)+(4*8)+(3*8)+(2*0)+(1*8)=209
209 % 10 = 9
So 775288-08-9 is a valid CAS Registry Number.

775288-08-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name hexahydro-1-methyl-4-(1-oxo-2-propenyl)-1H-1,4-diazepine

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:775288-08-9 SDS

775288-08-9Relevant academic research and scientific papers

COVALENT TARGETING OF E3 LIGASES

-

Paragraph 0591; 0623; 0700; 0742; 0816; 0868-0869, (2020/05/19)

Disclosed herein, inter alia, are compositions and methods for targeting E3 ligases. In an aspect is a targeted protein degrader including 1) a targeted protein binder and 2) an E3 Ubiquitin ligase binder, wherein the E3 Ubiquitin ligase is human RNF4 or human RNF114. In an aspect is provided a pharmaceutical composition including a compound as described herein, including embodiments, and a pharmaceutically acceptable excipient.

Benzenesulphonamide derivatives, method for production and use thereof for treatment of pain

-

Page/Page column 13-14, (2008/06/13)

The present invention concerns novel benzenesulphonamide compounds, defined by formula I and the description, their method of preparation and their use in therapy.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 775288-08-9